The Journal of Cell Biology,
Год журнала:
2020,
Номер
219(8)
Опубликована: Июль 1, 2020
Neuroinflammation
and
necroptosis
are
major
contributors
to
neurodegenerative
disease,
axon
dysfunction
degeneration
is
often
an
initiating
event.
SARM1
the
central
executioner
of
pathological
degeneration.
Here,
we
demonstrate
functional
mechanistic
links
among
these
three
pro-degenerative
processes.
In
a
neuroinflammatory
model
glaucoma,
TNF-α
induces
SARM1-dependent
degeneration,
oligodendrocyte
loss,
subsequent
retinal
ganglion
cell
death.
also
triggers
in
sensory
neurons
via
noncanonical
necroptotic
signaling
mechanism.
MLKL
final
canonical
necroptosis;
however,
axonal
necroptosis,
does
not
directly
trigger
Instead,
loss
survival
factors
NMNAT2
STMN2
activate
NADase
activity,
which
leads
calcium
influx
Hence,
findings
define
specialized
form
necroptosis.
The
demonstration
that
signals
can
act
locally
stimulate
identifies
therapeutically
targetable
mechanism
by
neuroinflammation
disease.
Science,
Год журнала:
2019,
Номер
365(6455), С. 793 - 799
Опубликована: Авг. 23, 2019
NAD
depletion
as
pathogen
response
One
way
that
plants
respond
to
infection
is
by
sacrificing
the
infected
cells.
The
nucleotide-binding
leucine-rich
repeat
immune
receptors
responsible
for
this
hypersensitive
carry
Toll/interleukin-1
receptor
(TIR)
domains.
In
two
papers,
Horsefield
et
al.
and
Wan
report
these
TIR
domains
cleave
metabolic
cofactor
nicotinamide
adenine
dinucleotide
(NAD
+
)
part
of
their
cell-death
signaling
in
pathogens.
Similar
links
mammalian
TIR-containing
proteins
during
Wallerian
degeneration
neurons.
Science
,
issue
p.
793
799
Journal of Neurology,
Год журнала:
2019,
Номер
267(7), С. 1896 - 1905
Опубликована: Март 28, 2019
Bell's
palsy
is
the
most
common
condition
involving
a
rapid
and
unilateral
onset
of
peripheral
paresis/paralysis
seventh
cranial
nerve.
It
affects
11.5–53.3
per
100,000
individuals
year
across
different
populations.
health
issue
causing
concern
has
an
extremely
negative
effect
on
both
patients
their
families.
Therefore,
diagnosis
prompt
cause
determination
are
key
for
early
treatment.
However,
etiology
unclear,
this
its
Thus,
it
critical
to
determine
causes
so
that
targeted
treatment
approaches
can
be
developed
employed.
This
article
reviews
literature
examines
possible
etiologies
disorder.
also
suggests
idiopathic
facial
based
exclusion
often
made
five
factors
including
anatomical
structure,
viral
infection,
ischemia,
inflammation,
cold
stimulation
responsivity.
Brain,
Год журнала:
2016,
Номер
139(12), С. 3092 - 3108
Опубликована: Окт. 25, 2016
Peripheral
polyneuropathy
is
a
common
and
dose-limiting
side
effect
of
many
important
chemotherapeutic
agents.
Most
such
neuropathies
are
characterized
by
early
axonal
degeneration,
yet
therapies
that
inhibit
this
destruction
process
do
not
currently
exist.
Recently,
we
others
discovered
genetic
deletion
SARM1
(sterile
alpha
TIR
motif
containing
protein
1)
dramatically
protects
axons
from
degeneration
after
axotomy
in
mice.
This
finding
fuels
hope
inhibition
or
its
downstream
components
can
be
used
therapeutically
patients
threatened
loss.
However,
axon
loss
most
neuropathies,
including
chemotherapy-induced
peripheral
neuropathy,
the
result
subacute/chronic
processes
may
regulated
differently
than
acute,
one
time
insult
axotomy.
Here
evaluate
if
decreases
mouse
model
neuropathy
induced
agent
vincristine.
In
wild-type
mice,
4
weeks
twice-weekly
intraperitoneal
injections
1.5
mg/kg
vincristine
cause
pronounced
mechanical
heat
hyperalgesia,
significant
decrease
tail
compound
nerve
action
potential
amplitude,
intraepidermal
fibres
myelinated
both
distal
sural
nerves
toe.
Neither
proximal
nor
motor
tibial
exhibit
These
findings
consistent
with
development
distal,
sensory
predominant
mimics
vincristine-induced
humans.
Using
same
regimen
treatment
knockout
hyperalgesia
blocked
amplitude
prevented.
Moreover,
mice
lose
unmyelinated
skin
toe
Hence,
blocks
Our
results
reveal
occurs
via
mediated
pathway,
blocking
pathway
prevents
polyneuropathy.
findings,
conjunction
previous
studies
traumatic
brain
injury,
establish
as
central
determinant
fundamental
activated
diverse
insults.
We
suggest
targeting
effectors
viable
therapeutic
option
to
prevent
possibly
other
polyneuropathies.
Frontiers in Neuroscience,
Год журнала:
2018,
Номер
12
Опубликована: Июль 11, 2018
Axons
are
electrically
excitable,
cable-like
neuronal
processes
that
relay
information
between
neurons
within
the
nervous
system
and
peripheral
target
tissues.
In
central
systems,
most
axons
over
a
critical
diameter
enwrapped
by
myelin,
which
reduces
internodal
membrane
capacitance
facilitates
rapid
conduction
of
electrical
impulses.
The
spirally
wrapped
myelin
sheath,
is
an
evolutionary
specialisation
vertebrates,
produced
oligodendrocytes
Schwann
cells;
in
mammals
myelination
occurs
during
postnatal
development
after
have
established
connection
with
their
targets.
Myelin
covers
vast
majority
axonal
surface,
influencing
axon's
physical
shape,
localisation
molecules
on
its
composition
extracellular
fluid
(in
periaxonal
space)
immerses
it.
unique
architecture
myelinated
axon,
crucial
to
function
as
conduit
long
distances,
renders
it
particularly
susceptible
injury
confers
specific
survival
maintenance
requirements.
Moreover,
myelinating
cells
play
fundamental
role
support,
at
least
part
providing
metabolic
substrates
underlying
axon
fuel
energy
this
review
we
will
describe
normal
morphology,
ultrastructure
axons,
discuss
how
these
change
following
disease,
or
experimental
perturbation,
particular
focus
cell
plays
shaping
supporting
axon.
Frontiers in Neuroscience,
Год журнала:
2017,
Номер
11
Опубликована: Авг. 31, 2017
Chemotherapeutic
agents
cause
many
short
and
long
term
toxic
side
effects
to
peripheral
nervous
system
that
drastically
alter
quality
of
life.
Chemotherapy-induced
neuropathy
(CIPN)
is
a
common
enduring
disorder
caused
by
several
anti-neoplastic
agents.
CIPN
typically
presents
with
neuropathic
pain,
numbness
distal
extremities
and/or
oversensitivity
thermal
or
mechanical
stimuli.
This
adverse
effect
often
requires
reduction
in
chemotherapy
dosage
even
discontinuation
treatment.
Currently
there
are
no
effective
treatment
options
for
CIPN.
While
the
underlying
mechanisms
not
understood,
current
data
identify
"dying
back"
axon
degeneration
nerve
endings
as
major
pathology
this
disorder.
Therefore,
mechanistic
understanding
will
provide
insights
into
pathway
molecular
players
responsible
Here,
we
review
recent
findings
expand
our
pathogenesis
discuss
pathways
may
be
shared
axonal
occurs
during
developmental
pruning
injury-induced
Wallerian
degeneration.
These
new
avenues
development
therapies
prevent
treat
Overexpression
of
the
NAD+
biosynthetic
enzyme
NMNAT1
leads
to
preservation
injured
axons.
While
increased
or
decreased
NMN
levels
are
thought
be
critical
this
process,
mechanism(s)
axon
protection
remain
obscure.
Using
steady-state
and
flux
analysis
metabolites
in
healthy
mouse
dorsal
root
ganglion
axons,
we
find
that
rather
than
altering
synthesis,
instead
blocks
injury-induced,
SARM1-dependent
consumption
is
central
degeneration.